HSPB1 and cancer: In recent years, clinical studies have identified HSP27 as a potential target and biological marker for the diagnosis, treatment, and prognosis of a variety of diseases, including cancer (15, 22, 23), neurological diseases (24–26), and CVDs (27–29).